Drug Companies pay the FDA for Drug Review - Is This a Conflict of Interest?

Avatar http://www.citizen.org Posted by admin 527 days ago

Today, drug companies pay a fee to the FDA for review of new drugs. This has been the case since 1992 with the passage of the Prescription Drug User Fee Act (PDUFA).

Some believe that this creates a conflict of interest in the FDA treats drug companies as clients rather than as entities to be monitored. The result has been a decline in safety standards at the FDA and a record number of drug withdrawals – totaling more than a dozen – for safety reasons.
Location: USA

Discuss | Trackback | Tags: fda drugs s. 1082 | Category: Federal | Add this link to... | Tell a friend

Comments


Log in to comment or register here.

Who supported this story


Sponsored by: Indoxyl Directory | Design by Student Web Designer | Powered By Pligg | Legal: License and Source Powered By Pligg | Legal: License and Source